
Sign up to save your podcasts
Or


Important trial on the podcast this week! I take a deep dive into the recently published SAPHYR study, which evaluated the use of the IL6 inhibitor sarilumab for patients with PMR. A few aggravating quibbles but overall a very useful trial and an important step forward for patients with PMR.
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2303452
By Michael Putman4.9
113113 ratings
Important trial on the podcast this week! I take a deep dive into the recently published SAPHYR study, which evaluated the use of the IL6 inhibitor sarilumab for patients with PMR. A few aggravating quibbles but overall a very useful trial and an important step forward for patients with PMR.
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2303452

323 Listeners

498 Listeners

878 Listeners

131 Listeners

1,145 Listeners

121 Listeners

191 Listeners

172 Listeners

67 Listeners

247 Listeners

4 Listeners

183 Listeners

11 Listeners

18 Listeners

6 Listeners